Table 3.
Metabolites studied in previous studies of Prostate cancer (PC).
| Metabolites | Samples (Methods) | Reference | Ethnos | |
|---|---|---|---|---|
| Up-Regulated | Down-Regulated | |||
| BCAA, glutamate; pseudouridine |
Glycine @, dimethylglycine @, fumarate, 4-imidazole-acetate |
Urine (1H-NMR) |
Pérez-Rambla et al. [46] | Spanish |
| glycocholic acid, hippurate, chenodeoxycholic acid |
5-Hydroxy-l-tryptophan, taurocholic acid |
Urine (FPLC/MS) |
Liang, et al. [47] | Chinese (Northern of China) |
| citrate, Myo-inositol, spermine |
EPS (1H-NMR) |
Serkova et al. [48] | American | |
| sarcosine | Urine/PT/Plasma (GC-MS) |
Sreekumr et al. [49] | American | |
| propenoic acid, dihyroxybutanoic acid xylonic acid |
pyrimidine, creatinine, purine, glucopyranoside, xylopyranoseand, ribofuranoside |
Urine (GC-MS) |
Wu et al. [50] | Chinese (Southern of China) |
@ opposite to the present study; EPS: Human expressed prostatic secretions; BCCA: Branched-chain amino acids; PT: Prostate Tissue; GC-MS: Gas chromatography/mass spectrometry; FPLC/MS: Faster ultrahigh performance liquid chromatography-mass spectrometry; 1H-NMRS: Proton nuclear magnetic resonance spectroscopy.